Report Detail

The global subcutaneous drug delivery devices market is expected to reach US$ 17,290.47 Mn in 2027 from US$ 9,243.80 in 2018. The market is estimated to grow with a CAGR of 7.4% from 2019-2027.
The increased number of chronic disease prevalence around the globe, significant number of vaccination and immunization programs that incorporate the use of subcutaneous drug delivery devices for therapeutic administration, rise in the research and development of new products leading to the subsequent introduction of novel solutions and devices in the market are expected to account for the growth of the market. However, risk of infections and other diseases associated with the use of injections and syringes is likely to hamper the market growth.
Research and development (R&D) is an essential and crucial part of the company’s business. Pharmaceutical and medical devices companies focus on the research and development (R&D) to come up with new molecules for various therapeutic applications with the greatest medical and commercial potential. The companies invest majorly on the R&Ds with the aim of delivering high quality and innovative products to the market. R&D spending by the biopharmaceutical companies has also increased over the years. According to a report of Pharmaceutical Research and Manufacturers of America (PhRMA), the R&D expenditure of the biopharmaceutical companies has increased from US$49.6 billion 2012 to US$ 58.8 billion in 2015. Also, Evonik Corporation has invested more than $50 million over the last 4 years to advance its competencies in medical devices, and production of RESOMER polymers for drug delivery and bio-reabsorbable medical devices. Thus the growing R&D expenditure drives the subcutaneous drug delivery systems market during the forecast period.
The global subcutaneous drug delivery devices market, based on the technology was segmented into syringes, pens, patches and others. In 2018, the syringes segment held the largest share of the market, by technology. However, the patches segmented is anticipated to witness fastest growth in the subcutaneous drug delivery devices market, based on technology. In the recent years, the increasing use of single-use syringes have helped to successfully reduce the rates of cross contamination thereby propelling the growth of syringes in the subcutaneous drug delivery devices market in the coming years.
Some of the major primary and secondary sources included in the report for the subcutaneous drug delivery devices Market are the World Health Organization, Organization For Economic Co-Operation And Development, Centers for Disease Control and Prevention, National Health Services, National Center for Biotechnology Information, Japan Chronic Disease Self-Management Association, Council Of Scientific And Industrial Research, and others.


TABLE OF CONTENTS

    1. Introduction

    • 1.1 Scope of the Study
    • 1.2 The Insight Partners Research Report Guidance
    • 1.3 Market Segmentation
      • 1.3.1 Global Subcutaneous Drug Delivery Devices Market - By Technology
      • 1.3.2 Global Subcutaneous Drug Delivery Devices Market - By Syringe Type
      • 1.3.3 Global Subcutaneous Drug Delivery Devices Market - By Distribution Channel
      • 1.3.4 Global Subcutaneous Drug Delivery Devices Market - By Geography

    2. Global Subcutaneous Drug Delivery Devices Market - Key Takeaways

      3. Research Methodology

      • 3.1 Coverage
      • 3.2 Secondary Research
      • 3.3 Primary Research

      4. Global Subcutaneous Drug Delivery Devices- Market Landscape

      • 4.1 Overview
      • 4.2 PEST Analysis
        • 4.2.1 North America PEST Analysis
        • 4.2.2 Europe PEST Analysis
        • 4.2.3 Asia Pacific - PEST Analysis
        • 4.2.4 Middle East & Africa- PEST Analysis
        • 4.2.5 South & Central America - PEST Analysis
      • 4.3 Expert Opinions

      5. Global Subcutaneous Drug Delivery Devices Market - Key Industry Dynamics

      • 5.1.1 Increasing Incidence of Chronic Diseases
      • 5.1.2 Increasing R&D Expenditures in Pharmaceutical And Medical Device Companies
      • 5.1.3 Technological Advancements and Increasing Product Launches
    • 5.2 Key Market Restraints
      • 5.2.1 Risks Associated with Injections:
    • 5.3 Key Market Opportunities
      • 5.3.1 Development of Products As Per Patient Compliance
    • 5.4 Future Trends
      • 5.4.1 Growing Product Innovations through Collaborative Research:
      • 5.4.2 Rapid Adoption of Pre-Filled Saline Syringes
    • 5.5 Impact Analysis
    • 6. Subcutaneous Drug Delivery Devices Market - Global Analysis

      • 6.1 Global Subcutaneous Drug Delivery Devices Market Revenue Forecasts And Analysis
      • 6.2 Global Subcutaneous Drug Delivery Devices Market, By Geography - Forecasts And Analysis
      • 6.3 Market Positioning of Key Players

      7. Subcutaneous Drug Delivery Devices Market Analysis And Forecasts To 2027 - Technology

      • 7.1 Overview
      • 7.2 Global Subcutaneous Drug Delivery Devices Market Share by Technology 2018 & 2027 (%)
      • 7.3 Syringes Market
        • 7.3.1 Overview
        • 7.3.2 Syringes Market Revenue and Forecast to 2027 (US$ Mn)
        • 7.3.3 Pens
          • 7.3.3.1 Overview
          • 7.3.3.2 Pens Market Revenue and Forecast to 2027 (US$ Mn)
        • 7.3.4 Patches
          • 7.3.4.1 Overview
          • 7.3.4.2 Patches Market Revenue and Forecast to 2027 (US$ Mn)
        • 7.3.5 Others
          • 7.3.5.1 Overview
          • 7.3.5.2 Others Market Revenue and Forecast to 2027 (US$ Mn)

        8. Subcutaneous Drug Delivery Devices Market Analysis And Forecasts To 2027 - Syringe Type

        • 8.1 Overview
        • 8.2 Global Subcutaneous Drug Delivery Devices Market Share by Syringe Type 2018 & 2027 (%)
        • 8.3 Prefilled Injectable Market
          • 8.3.1 Overview
          • 8.3.2 Prefilled Injectable Market Revenue and Forecast to 2027 (US$ Mn)
        • 8.4 Fillable Injectable Market
          • 8.4.1 Overview
          • 8.4.2 Fillable Injectable Market Revenue and Forecast to 2027 (US$ Mn)

        9. Subcutaneous Drug Delivery Devices Market Analysis And Forecasts To 2027 - Distribution Channel

        • 9.1 Overview
        • 9.2 Global Subcutaneous Drug Delivery Devices Market Share by Distribution Channel 2018 & 2027 (%)
        • 9.3 Hospital Pharmacies Market
          • 9.3.1 Overview
          • 9.3.2 Hospital Pharmacies Market Revenue and Forecast to 2027 (US$ Mn)
        • 9.4 Retail Pharmacies Market
          • 9.4.1 Overview
          • 9.4.2 Retail Pharmacies Market Revenue and Forecast to 2027 (US$ Mn)
        • 9.5 Online Pharmacies Market
          • 9.5.1 Overview
          • 9.5.2 Online Pharmacies Market Revenue and Forecast to 2027 (US$ Mn)

        10. Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 - Geographical Analysis

        • 10.1 North America Subcutaneous Drug Delivery Devices Market Revenue And Forecasts To 2027
          • 10.1.1 North America Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
        • 10.2 North America Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
        • 10.3 North America Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
        • 10.4 North America Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
          • 10.4.1 North America Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027, By Country (%)
          • 10.4.2 US Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
            • 10.4.2.1 US Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
            • 10.4.2.2 US Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
            • 10.4.2.3 US Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
            • 10.4.2.4 US Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
          • 10.4.3 Canada Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
            • 10.4.3.1 Canada Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
            • 10.4.3.2 Canada Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
            • 10.4.3.3 Canada Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
            • 10.4.3.4 Canada Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
          • 10.4.4 Mexico Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
            • 10.4.4.1 Mexico Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
            • 10.4.4.2 Mexico Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
            • 10.4.4.3 Mexico Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
            • 10.4.4.4 Mexico Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
        • 10.5 Europe Subcutaneous Drug Delivery Devices Market Revenue And Forecasts To 2027
          • 10.5.1 Europe Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
        • 10.6 Europe Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
        • 10.7 Europe Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
        • 10.8 Europe Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
          • 10.8.1 Europe Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027, By Country (%)
          • 10.8.2 UK Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
            • 10.8.2.1 UK Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
            • 10.8.2.2 UK Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
            • 10.8.2.3 UK Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
            • 10.8.2.4 UK Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
          • 10.8.3 Germany Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
            • 10.8.3.1 Germany Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
            • 10.8.3.2 Germany Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
            • 10.8.3.3 Germany Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
            • 10.8.3.4 Germany Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
          • 10.8.4 France Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
            • 10.8.4.1 France Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
            • 10.8.4.2 France Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
            • 10.8.4.3 France Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
            • 10.8.4.4 France Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
          • 10.8.5 Italy Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
            • 10.8.5.1 Italy Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
            • 10.8.5.2 Italy Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
            • 10.8.5.3 Italy Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
            • 10.8.5.4 Italy Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
          • 10.8.6 Spain Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
            • 10.8.6.1 Spain Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
            • 10.8.6.2 Spain Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
            • 10.8.6.3 Spain Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
            • 10.8.6.4 Spain Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

          11. Asia Pacific Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027

          • 11.1 Overview
          • 11.2 Asia Pacific Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
          • 11.3 Asia Pacific Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
          • 11.4 Asia Pacific Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
          • 11.5 Asia Pacific Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
          • 11.6 Asia Pacific Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027, By Country (%)
          • 11.7 Japan Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
            • 11.7.1 Japan Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
              • 11.7.1.1 Japan Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
              • 11.7.1.2 Japan Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
              • 11.7.1.3 Japan Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
          • 11.8 China Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
            • 11.8.1 China Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
              • 11.8.1.1 China Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
              • 11.8.1.2 China Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
              • 11.8.1.3 China Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
          • 11.9 India Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
            • 11.9.1 India Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
              • 11.9.1.1 India Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
              • 11.9.1.2 India Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
              • 11.9.1.3 India Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
          • 11.10 Australia Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
            • 11.10.1 Australia Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
              • 11.10.1.1 Australia Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
              • 11.10.1.2 Australia Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
              • 11.10.1.3 Australia Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
          • 11.11 South Korea Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
            • 11.11.1 South Korea Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
              • 11.11.1.1 South Korea Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
              • 11.11.1.2 South Korea Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
              • 11.11.1.3 South Korea Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

            12. Middle East & Africa Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027

            • 12.1 Overview
            • 12.2 Middle East & Africa Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
            • 12.3 Middle East and Africa Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
            • 12.4 Middle East and Africa Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
            • 12.5 Middle East and Africa Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
            • 12.6 Middle East & Africa Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027, By Country (%)
            • 12.7 South Africa Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
              • 12.7.1 South Africa Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
                • 12.7.1.1 South Africa Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
                • 12.7.1.2 South Africa Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
                • 12.7.1.3 South Africa Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
            • 12.8 Saudi Arabia Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
              • 12.8.1 Saudi Arabia Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
                • 12.8.1.1 Saudi Arabia Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
                • 12.8.1.2 Saudi Arabia Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
                • 12.8.1.3 Saudi Arabia Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
            • 12.9 UAE Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
              • 12.9.1 UAE Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
                • 12.9.1.1 UAE Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
                • 12.9.1.2 UAE Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
                • 12.9.1.3 UAE Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

              13. South and Central America Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027

              • 13.1 Overview
              • 13.2 South and Central America Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
              • 13.3 South and Central America Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
              • 13.4 South and Central America Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
              • 13.5 South and Central America Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
              • 13.6 South and Central America Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027, By Country (%)
              • 13.7 Brazil Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
              • 13.7.1.1 Brazil Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
              • 13.7.1.2 Brazil Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
              • 13.7.1.3 Brazil Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
              • 13.7.1.4 Brazil Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
            • 13.7.2 Argentina Subcutaneous Drug Delivery Devices Market
              • 13.7.2.1 Argentina Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
              • 13.7.2.2 Argentina Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
              • 13.7.2.3 Argentina Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
              • 13.7.2.4 Argentina Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

            14. Subcutaneous Drug Delivery Devices Market - Industry Landscape

            • 14.1 Overview
            • 14.2 Growth Strategies done by the companies in the Market, (%)
            • 14.3 Organic Developments
              • 14.3.1 Overview
            • 14.4 Inorganic developments
              • 14.4.1 Overview

            15. Subcutaneous Drug Delivery Devices Market - Key Company Profiles

            • 15.1 Insulet Corporation
              • 15.1.1 Key Facts
              • 15.1.2 Business Description
              • 15.1.3 Financial Information
              • 15.1.4 Product Portfolio
              • 15.1.5 SWOT Analysis
              • 15.1.6 Key Developments
            • 15.2 BD
              • 15.2.1 Key Facts
              • 15.2.2 Business Description
              • 15.2.3 Financial Overview
              • 15.2.4 Product Portfolio
              • 15.2.5 SWOT Analysis
              • 15.2.6 Key Developments
            • 15.3 Amgen Inc.
              • 15.3.1 Key Facts
              • 15.3.2 Business Description
              • 15.3.3 Financial Overview
              • 15.3.4 Product Portfolio
              • 15.3.5 SWOT Analysis
              • 15.3.6 Key Developments
            • 15.4 ELCAM Medical
              • 15.4.1 Key Facts
              • 15.4.2 Business Description
              • 15.4.3 Financial Overview
              • 15.4.4 Product Portfolio
              • 15.4.5 SWOT Analysis
              • 15.4.6 Key Developments.
            • 15.5 Ypsomed AG
              • 15.5.1 Key Facts
              • 15.5.2 Business Description
              • 15.5.3 Financial Information
              • 15.5.4 Product Portfolio
              • 15.5.5 SWOT Analysis
              • 15.5.6 Key Developments
            • 15.6 West Pharmaceutical Services, Inc
              • 15.6.1 Key Facts
              • 15.6.2 Business Description
              • 15.6.3 Financial Information
              • 15.6.4 Product Portfolio
              • 15.6.5 SWOT Analysis
              • 15.6.6 Key Developments
            • 15.7 Scpharmaceuticals, Inc.
              • 15.7.1 Key Facts
              • 15.7.2 Business Description
              • 15.7.3 Financial Overview
              • 15.7.4 Product Portfolio
              • 15.7.5 SWOT Analysis
              • 15.7.6 Key Developments.
            • 15.8 Wilhelm Haselmeier GmbH and Co. KG
              • 15.8.1 Key Facts
              • 15.8.2 Business Description
              • 15.8.3 Financial Overview
              • 15.8.4 Product Portfolio
              • 15.8.5 SWOT Analysis
              • 15.8.6 Key Developments
            • 15.9 Consort Medical PLC
              • 15.9.1 Key Facts
              • 15.9.2 Business Description
              • 15.9.3 Financial Overview
              • 15.9.4 Product Portfolio
              • 15.9.5 SWOT Analysis
              • 15.9.6 Key Developments
            • 15.10 Enable Injections, Inc.
              • 15.10.1 Key Facts
              • 15.10.2 Business Description
              • 15.10.3 Financial Overview
              • 15.10.4 Product Portfolio
              • 15.10.5 SWOT Analysis
              • 15.10.6 Key Developments

            16. Appendix

            • 16.1 About The Insight Partners
            • 16.2 Glossary Of Terms

      Summary:
      Get latest Market Research Reports on Subcutaneous Drug Delivery Devices . Industry analysis & Market Report on Subcutaneous Drug Delivery Devices is a syndicated market report, published as Subcutaneous Drug Delivery Devices Market to 2027 - Global Analysis and Forecasts by Technology (Syringes, Pens, Patches, Others); Syringe Type (Prefilled Injectable, Filled Injectable); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Geography. It is complete Research Study and Industry Analysis of Subcutaneous Drug Delivery Devices market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $4,550.00
      $6,550.00
      $8,550.00
      3,635.45
      5,233.45
      6,831.45
      4,245.15
      6,111.15
      7,977.15
      707,752.50
      1,018,852.50
      1,329,952.50
      379,151.50
      545,811.50
      712,471.50
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report